Educational information only. Not medical advice, not a diagnosis, and not an offer to sell any product. These are experimental or unapproved substances; we do not provide dosage, sourcing, or use guidance. Consult a licensed clinician. We link to official sources only.
A tripeptide of lysine, proline and valine, related to alpha-MSH fragments. Marketed mainly for topical anti-inflammatory and skin/gut applications.
More plausible as a topical/skin-adjacent story than an injectable performance story; appears in wound-healing and inflammation discussions.
| Claim | Strongest evidence |
|---|---|
| Anti-inflammatory / wound healing | R Regulatory only |
| Skin / gut | D Cell / mechanistic |
FDA found no approved-drug component or USP/NF monograph and proposed not adding KPV, citing lack of human safety/effectiveness information.
No human safety/effectiveness data. Marketing claims often imply drug effects without support.
No. FDA found no monograph and proposed not adding it; it is not an established supplement ingredient.
Choose your main interest, then get one email when regulatory status changes or strong new evidence lands. Health topics only. Unsubscribe anytime.
Educational information only. Not medical advice, not a diagnosis, and not an offer to sell any product. These are experimental or unapproved substances; we do not provide dosage, sourcing, or use guidance. Consult a licensed clinician. We link to official sources only.